Which entities are typically included in the drug supply chain path from manufacture to the end user?

Which entities are typically included in the drug supply chain path from manufacture to the end user?

• A. Manufacturer, the wholesale drug distributor, and the pharmacy.
• B. Only the manufacturer.
• C. Hospitals and clinics.
• D. Regulatory agencies.

Answer: (A)

From production to the patient, the typical flow involves the manufacturer creating the drug, a wholesale distributor moving it in bulk to retail points, and a pharmacy dispensing it to the end user. This chain helps ensure proper storage, tracking, and delivery at each step before the patient receives the medication. Hospitals and clinics may receive drugs, and regulatory agencies oversee safety and compliance, but they aren’t the direct links in the immediate path from manufacture to the end user. That’s why involving the manufacturer, the wholesale distributor, and the pharmacy best describes the standard drug supply chain path.

From production to the patient, the typical flow involves the manufacturer creating the drug, a wholesale distributor moving it in bulk to retail points, and a pharmacy dispensing it to the end user. This chain helps ensure proper storage, tracking, and delivery at each step before the patient receives the medication. Hospitals and clinics may receive drugs, and regulatory agencies oversee safety and compliance, but they aren’t the direct links in the immediate path from manufacture to the end user. That’s why involving the manufacturer, the wholesale distributor, and the pharmacy best describes the standard drug supply chain path.